These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35313796)

  • 1. Inhibition of lncRNA NEAT1 sensitizes medulloblastoma cells to cisplatin through modulating the miR-23a-3p-glutaminase (GLS) axis.
    Ge J; Wang B; Zhao S; Xu J
    Bioengineered; 2022 Mar; 13(3):7670-7682. PubMed ID: 35313796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis.
    Zhu L; Wang F; Fan W; Jin Z; Teng C; Zhang J
    Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1198-1206. PubMed ID: 34327529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting lncRNA NEAT1 facilitates the sensitization of melanoma cells to cisplatin through modulating the miR-519c-3p-MeCP2 axis.
    Chen Y; Chang Y; Zhou J; Lv L; Ying H
    Pathol Res Pract; 2023 Mar; 243():154364. PubMed ID: 36841132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of lncRNA NEAT1 induces dysfunction of fibroblast-like synoviocytes in rheumatoid arthritis via miRNA-338-3p-mediated regulation of glutamine metabolism.
    Zhang M; Lu N; Li HJ; Guo XY; Lu L; Guo Y
    J Orthop Surg Res; 2022 Sep; 17(1):401. PubMed ID: 36050752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of LncRNA-NEAT1 alleviates intestinal epithelial cells (IECs) dysfunction in ulcerative colitis by maintaining the homeostasis of the glucose metabolism through the miR-410-3p-LDHA axis.
    Ni S; Liu Y; Zhong J; Shen Y
    Bioengineered; 2022 Apr; 13(4):8961-8971. PubMed ID: 35735114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-141-3p Promotes the Cisplatin Sensitivity of Osteosarcoma Cell through Targeting the Glutaminase [GLS]-Mediated Glutamine Metabolism.
    Zhou X; Wei P; Wang X; Zhang J; Shi Y
    Curr Mol Med; 2023; 23(2):177-184. PubMed ID: 34607540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin Synergizes with Cisplatin to Inhibit Colon Cancer through Targeting the MicroRNA-137-Glutaminase Axis.
    Fan WH; Wang FC; Jin Z; Zhu L; Zhang JX
    Curr Med Sci; 2022 Feb; 42(1):108-117. PubMed ID: 34958454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Long Noncoding RNA CRNDE Increases Chemosensitivity of Medulloblastoma Cells by Targeting miR-29c-3p.
    Sun XH; Fan WJ; An ZJ; Sun Y
    Oncol Res; 2020 Feb; 28(1):95-102. PubMed ID: 31753063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA NEAT1 modulates cell proliferation and apoptosis by regulating miR-23a-3p/SMC1A in acute myeloid leukemia.
    Zhao C; Wang S; Zhao Y; Du F; Wang W; Lv P; Qi L
    J Cell Physiol; 2019 May; 234(5):6161-6172. PubMed ID: 30246348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming cisplatin resistance of human lung cancer by sinomenine through targeting the miR-200a-3p-GLS axis.
    Liu X; Chen L; Wang T
    J Chemother; 2023 Jul; 35(4):357-366. PubMed ID: 36120905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p.
    Hua G; Zeng ZL; Shi YT; Chen W; He LF; Zhao GF
    Pharmacology; 2021; 106(9-10):498-508. PubMed ID: 34352791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis.
    Shao X; Zheng X; Ma D; Liu Y; Liu G
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 33645623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of lncRNA NEAT1 in endometriosis and its biological functions in ectopic endometrial cells as mediated via miR-124-3p.
    Yuan D; Zhu D; Yin B; Ge H; Zhao Y; Huang A; Wang X; Cao X; Xia N; Qian H
    Genes Genomics; 2022 May; 44(5):527-537. PubMed ID: 35094286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA NEAT1 Knockdown Ameliorates 1-Methyl-4-Phenylpyridine-Induced Cell Injury Through MicroRNA-519a-3p/SP1 Axis in Parkinson Disease.
    Wang S; Wen Q; Xiong B; Zhang L; Yu X; Ouyang X
    World Neurosurg; 2021 Dec; 156():e93-e103. PubMed ID: 34508910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
    Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.
    Cui Z; Wang Q; Deng MH; Han QL
    Cancer Biomark; 2022; 34(1):41-53. PubMed ID: 34542064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA NEAT1 promotes endometrial cancer cell proliferation, migration and invasion by regulating the miR-144-3p/EZH2 axis.
    Wang W; Ge L; Xu XJ; Yang T; Yuan Y; Ma XL; Zhang XH
    Radiol Oncol; 2019 Nov; 53(4):434-442. PubMed ID: 31747378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ceRNA regulatory network involving the long noncoding NEAT1, miRNA-466f-3p and its mRNA target in osteoblast autophagy and osteoporosis.
    Zhao X; Zhao D; Geng B; Yaobin W; Xia Y
    J Mol Med (Berl); 2022 Nov; 100(11):1629-1646. PubMed ID: 36169673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NEAT1/miR-140-3p/MAPK1 mediates the viability and survival of coronary endothelial cells and affects coronary atherosclerotic heart disease.
    Zhang H; Ji N; Gong X; Ni S; Wang Y
    Acta Biochim Biophys Sin (Shanghai); 2020 Sep; 52(9):967-974. PubMed ID: 32844995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NEAT1/miR-23a-3p/KLF3: a novel regulatory axis in melanoma cancer progression.
    Ding F; Lai J; Gao Y; Wang G; Shang J; Zhang D; Zheng S
    Cancer Cell Int; 2019; 19():217. PubMed ID: 31462890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.